Market Research Report
Respiratory Syncytial Virus Vaccines
|Published by||Datamonitor Healthcare||Product code||858205|
|Published||Content info||209 Pages
Delivery time: 1-2 business days
|Respiratory Syncytial Virus Vaccines|
|Published: October 5, 2018||Content info: 209 Pages||
Respiratory syncytial virus (RSV) is an enveloped, non-segmented, single-stranded, negative-sense RNA virus belonging to the Paramyxoviridae family. RSV is the leading cause of bronchiolitis in infants, and is estimated to be responsible for 22% of all episodes of acute lower respiratory tract infections in young children. Almost all children are infected with RSV within the first two years of life, and approximately 0.5-2.0% of infections will result in hospitalization. RSV is also recognized as a major cause of morbidity in immunosuppressed adults and the elderly.